Home News Последни новини The audit committee did not approve the specification for medicines
Main menu
Home
News
Lawsuits
Patients rights
Services
Contacts
Registration
Регистрацията ще Ви позволи да получите допълнителна информация, както и да получавате съобщения при излизането на нова статия.





Lost Password?
No account yet? Register
latest
About us
Our mission
Founders
Donations
Useful links
Forum
 петък, 03 септември 2010
The audit committee did not approve the specification for medicines PDF Print E-mail
 At its second meeting since it was created the Audit committee has not approved the specification for medicines under Regulation 34. The first surprise to some of the members of the committee has been that the proposed list of medicines and quantities for which there will be tenders is different from the list determined by the commission that prepared the document. For many of the medicines there was a substantial discrepancy between the quantities ordered by the dispensary clinics and these set by the ministry. It turned out as well that there are medicines that are included in Regulation 34 but are lacking in the specification and visa versa. The most confusing is however that most medicines for treatment of rare diseases are missing. So despite the accepted Programme for treatment of rare diseases and the loud promises of the politicians to secure it financially the patients with the Goshe disease, with mucopolysaccharidosis and many others may be left without medicines for 2010. Finally the Audit committee did not accept the specification proposed by the consultant Dudov and returned it for corrections to the commission. The majority of the experts however think that there will not be substantial changes due to the pressing deadlines of the tender procedures. So with the excuse of the lack of time all will face an accomplished fact
 
< Prev   Next >
  • Български
  • English
With support of

The America for Bulgaria Foundation (ABF) assists in the development and growth of a vibrant private sector for the benefit of a free and democratic Bulgaria. Founded in 2008, the ABF is a successor to the Bulgarian American Enterprise Fund, an investment fund created by the U.S. government acting through the U.S. Agency for International Development. The grants provided by ABF will build on the legacy of goodwill and friendship that exists between the American people and the citizens of Bulgaria.

 

 

in cooperation with:

 

Associated member of:
Advertisement
Rights

European Union Charter of Fundamental Rights


Convention for the protection of Human Rights and Fundamental Freedoms


European charter of patients rights
Hipporatic oath 
Poll
Каква е причината за липса на пари за здравеопазване?
 
 
Go to top of page  Home | News | Lawsuits | Patients rights | Services | Contacts |